Pfizer Inc
Follow13F filer, CIK 78003, New York, NY
Pfizer Inc reported $164,248,920 across 17 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-12. Its ten largest share positions make up 95.1% of the portfolio.
Accepted , ingested 13F-HR 0000078003-26-000135
- Period
- 2026-09-30
- Reported value
- $164M
- Holdings
- 17
- Top 10 weight
- 95.1%
- New
- 2
- Sold out
- 2
Part of the filer group Pfizer Inc
- PFIZER INC. (13-5315170)
- PFIZER VENTURES (US) LLC (82-5524518)
Stakes and trades reported after 2026-09-30
13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.
- TRXB TREX BIO INC: 13G 1,965,066 shares, 7.2% of the class, 13G filed 2026-10-16, 0000078003-26-000118Timeline
Accepted , ingested
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| AGMBadded | +2,076,213 | $21.8M |
| WVEnew | +1,875,000 | $7.09M |
| SENSnew | +2,171 | $21.7K |
| NXTCadded | +10 | $50 |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| WVEexited | -1,875,000 | -$10.9M |
| SENSEONICS HOLDINGS INCexited | -2,171 | -$12.4K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2026
Share positions as resolved from 13F-HR 0000078003-26-000135, largest first. % of portfolio is the value over $164,248,920, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| ALLOALLOGENE THERAPEUTICS INC | 22,032,040 | $36.4M | 22.13% | 0 | Timeline | ||
| ARVNARVINAS INC | 3,457,815 | $26.2M | 15.98% | 0 | Timeline | ||
| CELCCELCUITY INC | 295,652 | $23.5M | 14.31% | 0 | Timeline | ||
| AGMBAGOMAB THERAPEUTICS NV | 2,151,213 | $22.6M | 13.77% | +2,076,213 | Timeline | ||
| PYXSPYXIS ONCOLOGY INC | 7,032,770 | $20.1M | 12.25% | 0 | Timeline | ||
| WVEWAVE LIFE SCIENCES INC | 1,875,000 | $7.09M | 4.32% | new | Timeline | ||
| BHVNBIOHAVEN LTD | 505,645 | $6.57M | 4% | 0 | Timeline | ||
| CRBUCARIBOU BIOSCIENCES INC | 4,690,431 | $5.82M | 3.54% | 0 | Timeline | ||
| ORICORIC PHARMACEUTICALS INC | 372,904 | $4.91M | 2.99% | 0 | Timeline | ||
| CRDFCARDIFF ONCOLOGY INC | 2,411,575 | $2.99M | 1.82% | 0 | Timeline | ||
| SPROSPERO THERAPEUTICS INC | 2,362,348 | $2.91M | 1.77% | 0 | Timeline | ||
| ZNTLZENTALIS PHARMACEUTICALS INC | 953,834 | $2.58M | 1.57% | 0 | Timeline | ||
| ZURAZURA BIO LTD | 538,841 | $2.18M | 1.33% | 0 | Timeline | ||
| NXTCNEXTCURE INC | 44,357 | $225K | 0.14% | +10 | Timeline | ||
| BOLTBOLT BIOTHERAPEUTICS INC | 31,305 | $112K | 0.07% | 0 | Timeline | ||
| DNAGINKGO BIOWORKS HOLDINGS INC | 2,928 | $31.2K | 0.02% | 0 | Timeline | ||
| SENSSENSEONICS HLDGS INC | 2,171 | $21.7K | 0.01% | new | Timeline |
Sold out in Q3 2026
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| WVEWAVE LIFE SCIENCES LTD | 1,875,000 | $10.9M | shares |
| SENSEONICS HOLDINGS INCSENSEONICS HOLDINGS INC | 2,171 | $12.4K | shares |
How Q3 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000078003-26-000135 | base | 2026-11-12 |